Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene therapy for age-related macular degeneration: a promising frontier in vision preservation

20 May 2025

Abstract excerpt

Age-related macular degeneration (AMD) is a leading cause of central vision loss, progressively impairing the retina and affecting millions worldwide. By 2040, global cases of AMD are projected to reach 300 million, posing a significant public health challenge. While early AMD may only cause mild visual impairment, advanced stages, particularly neovascular (wet) and non-neovascular (dry) AMD, can lead to severe...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Retinal Development and Disorders
Share to Retinal Diseases and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40394614
DOI: 10.1186/s12964-025-02246-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene therapy for age-related macular degeneration: a promising frontier in vision preservationPMID 40394614Read ↗

New Generation of Gene Therapies as the Future of Wet AMD TreatmentSemantic proximity Read ↗

A New Generation of Gene Therapies as the Future of Wet AMD TreatmentSemantic proximity Read ↗

Gene therapy for age-related macular degenerationSemantic proximity Read ↗

Gene therapy in neovascular age related macular degeneration: an updateSemantic proximity Read ↗

Advancements in age-related macular degeneration treatment: From traditional anti-VEGF to emerging therapies in gene, stem cell, and nanotechnologySemantic proximity Read ↗

A Systematic Review; Efficacy Assessment of Novel Therapy in Treating Age-related Macular DegenerationSemantic proximity Read ↗

Gene therapy in age related macular degeneration and hereditary macular disordersSemantic proximity Read ↗

The genetics of age-related macular degeneration (AMD)--Novel targets for designing treatment options?Semantic proximity Read ↗

Multiple gene therapy as a tool for regulating the expression of molecules involved in neovascular age-related macular degenerationSemantic proximity Read ↗

The Role of Gene Therapy in the Treatment of Retinal Diseases: A ReviewSemantic proximity Read ↗

Gene Therapy for Non-Hereditary Retinal Disease: Age-Related Macular Degeneration, Diabetic Retinopathy, and BeyondSemantic proximity Read ↗

Targeting vascular endothelial growth factor using retinal gene therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.